ABGENIX
USPTO Trademark Record · Serial No. 75118177
Trademark details
It was initially claimed by ABGENIX, INC. on 19960613.
That brand applies to the following goods and services:biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals, pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases, animal embryos for laboratory use, pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others.
Currently that trademark is represented by trademark attorney(s): BETH M. GOLDMAN.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the ABGENIX trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
